Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
1.48M
-
Shares change
-
+946K
-
Total reported value, excl. options
-
$3.94M
-
Value change
-
+$2.5M
-
Number of buys
-
8
-
Number of sells
-
-3
-
Price
-
$2.65
Significant Holders of Acurx Pharmaceuticals, Inc. - COM (ACXP) as of Q2 2023
14 filings reported holding ACXP - Acurx Pharmaceuticals, Inc. - COM as of Q2 2023.
Acurx Pharmaceuticals, Inc. - COM (ACXP) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.48M shares
.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (1.18M shares), VANGUARD GROUP INC (121K shares), GEODE CAPITAL MANAGEMENT, LLC (77.3K shares), OSAIC HOLDINGS, INC. (22K shares), BlackRock Inc. (18.9K shares), TD Waterhouse Canada Inc. (18.7K shares), MILLENNIUM MANAGEMENT LLC (17.3K shares), One68 Global Capital, LLC (13K shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (10.1K shares), and Tower Research Capital LLC (TRC) (4.45K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.